Rheumatoid arthritis treatment Archives | Page 2 of 8 | Rheumatoid Arthritis Warrior

Rheumatoid Symptoms Persist Despite Treatment: a Study in Juveniles (JRA / JIA)

In spite of treatment advances including biologics, children affected by Rheumatoid Disease still experience pain, stiffness, and fatigue that impacts their ability to function. The disease may not be as “controlled” as many doctors presume. This may not be news to you as a patient or caregiver, but as these researchers point out, it needs...Continue reading      5 Comments » Read more

20 Essential Medication Safety Tips

Essential medication safety tips (UPDATED) For those living with a chronic disease, safe medication storage and use is more than following directions on an occasional antibiotic or treatment for an acute illness. Both the types of medications and the number of different medications present additional challenges and put people at greater risk for adverse drug events...Continue reading      22 Comments » Read more

Triple Therapy / Combination Therapy for Rheumatoid Arthritis

Treatments for Rheumatoid Arthritis In the past few decades, Rheumatoid Arthritis has been treated with therapies designed for other diseases. It was not always clear how these drugs treated Rheumatoid Arthritis / Rheumatoid Disease, but they were found to reduce immune activity in various ways. Because researchers recognized certain drugs could slow or modify progression of...Continue reading      5 Comments » Read more

Rheumatoid Arthritis (RA) Treat to Target

The treat to target (T2T) approach involves defining a treatment goal or “target” and modifying the therapy if the target is not reached. Treating to a target of remission or low disease activity Treat to target (T2T) is an approach to treating Rheumatoid Arthritis / Rheumatoid Disease (RD) that combines aggressive or intensive treatment with disease modifying...Continue reading      2 Comments » Read more

News on Biosimilar Biologics for Rheumatoid Arthritis / Rheumatoid Disease

Little progress on FDA path of biosimilar biologics for RD It’s hard to believe it’s been almost two years since we’ve discussed biosimilars on Rheumatoid Arthritis Warrior (RAW). What’s even harder to believe: the situation in the U.S. is much the same: 1) The Biologics Price Competition and Innovation Act (BPCI) was created as a pathway for...Continue reading      1 Comment » Read more

Efficacy of Xeljanz, Biologics, & DMARDs in Rheumatoid Disease

Why should I feel like I failed? I’m not alone We probably agree it’s unfair to say, “patients fail treatments” instead of the reverse, but there is still disappointment. I was optimistic that my Rheumatoid disease would respond to Xeljanz, the new oral DMARD (disease modifying anti-rheumatic drug) from Pfizer. Unfortunately, my joint stiffness and inflammation,...Continue reading      47 Comments » Read more

New Treatments for Rheumatoid Arthritis: the Research Road

Is there an RA miracle treatment right around the corner? Thanks to my mom and a couple of other RA-news watchers who sent me this news Friday about a so-called “single jab to beat arthritis.” Why do papers love stupid headlines? No, it’s not about “arthritis;” it’s about RA, an ill-named inflammatory disease. It’s not a...Continue reading      9 Comments » Read more
“imaware™
    Advertisement

Would You Like Free Email Updates?

Stay in touch with RA Warrior.

We respect your privacy. Your email address will never be shared.